##

- Deep Dive into the Management of Myelodysplastic Syndromes
- The Changing Landscape of Myelodysplastic Syndromes Treatment
- Some Highlighted Studies

##

- Clinical Insights into Managing Myeloma
- Challenges in Multiple Myeloma: Renal Failure
- Some Highlighted Studies

##

- Deciding the Optimum Treatment Options for Acute Myeloid Leukemia
- Deep Dive into the Acute Myeloid Leukemia Treatment Scenario
- New Evidence and Innovative Therapeutics in Acute Myeloid Leukemia
- Some Highlighted Studies

##

##

#### View

# Latest Insights on COVID-19

Patients with Coronavirus disease 2019 or COVID-19 have coagulopathy and are at a high risk of thrombosis and death.39

A prophylactic dose of low-molecular–weight heparin is recommended as per the American Society of Hematology guidelines.40,41

Ongoing studies can test strategies to guide school reopening, on-site testing, treatment for influenza in homeless centers, household transmission studies, and community-based vaccine effectiveness study (ASH 2020).

Bio-specimen repositories linked with clinical data are essential for real-time identification of novel pathogens (ASH 2020).

Community-based studies provide an opportunity to identify pathogens early and take steps to prevent further transmission (ASH 2020).